adimin

OrbiMed executives acquire $499,984 worth of BiomX Inc. warrants

Executives from OrbiMed, a leading investment firm in the healthcare sector, have recently made significant purchases of derivative securities from BiomX Inc. (NYSE:PHGE), a company specializing in biological products. This move indicates a bolstered interest in the biotech firm\'s future potential. The transactions, which took place on March 15, 2024, involved OrbiMed Israel BioFund GP...

Read More

UiPath CFO sells $365k in company stock

UiPath Inc. (NYSE:PATH) reported that its Chief Financial Officer, Ashim Gupta, sold a total of 16,000 shares of the company\'s Class A Common Stock on March 15, 2024. The transaction, part of a pre-arranged 10b5-1 trading plan, totaled approximately $365,369, with share prices ranging from $22.65 to $23.15. The sale was executed in compliance with...

Read More